Septerna, Inc.

SEPN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.1B · 130 employees
34
SEC Filings
$39.5
Close 2026-09-17
130
Employees

Business Summary

Septerna, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oral small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes its proprietary Native Complex Platform to develop product candidates including SEP-479 and SEP-631. Septerna has a partnership with Novo Nordisk A/S to develop oral small molecule therapies for metabolic-related diseases targeting GLP-1, GIP, and glucagon receptors for obesity, type 2 diabetes, and related conditions.

Latest Stock Quote

SEPN 2026-09-17 $39.5 O:$39.38 H:$40.52 L:$39.005 Vol:0.3M VWAP:$39.6946
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098507EDGAR122K words
2025-03-272024-12-310000950170-25-045745EDGAR118K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-102026-06-300001193125-26-342353EDGAR81K words
2025-11-102025-09-300001193125-25-273375EDGAR33K words
2025-08-112025-06-300000950170-25-106551EDGAR27K words
2025-05-152025-03-310000950170-25-072619EDGAR22K words
2024-11-202024-09-300000950170-24-129274EDGAR79K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-250001193125-26-364210EDGAR0K words
2026-08-100001193125-26-342328EDGAR2K words
2026-03-090001193125-26-098489EDGAR2K words
2026-03-020001193125-26-084142EDGAR3K words
2026-01-120001193125-26-009864EDGAR3K words
2026-01-080001193125-26-007772EDGAR0K words
2025-11-100001193125-25-273373EDGAR2K words
2025-09-290001193125-25-223292EDGAR1K words
2025-09-030001193125-25-194472EDGAR3K words
2025-08-210001193125-25-184706EDGAR1K words

34 total filings indexed. 17 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

obesity type-2-diabetes metabolic-related-diseases

Company Identity

CIK0001984086
TickerSEPN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.septerna.com
Listed2024-10-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: d842728de00c96d2b1ae7f610833ea7a29b0c4e2510188077e9b4d80fdf2d762
parent: 13bdf391e3d8714cafba5b79f94c410ff4e73fcbbd6722a74c0b67d65289cdd4
content hash: 1b12ecc82caed5202f99dc8a3110eb6f192ca5c200191fd972cebc54d3464550
signed: 2026-10-13T19:03:07.413Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SEPN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SEPN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SEPN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.